Rapport Therapeutics, Inc. · NASDAQ:RAPP
Maraganore John bought 9,411 Rapport Therapeutics, Inc. shares (Form 4)
Traded Oct 22, 2026 · Filed Oct 22, 2026
On Oct 22, 2026, Maraganore John (Director) bought 9,411 Rapport Therapeutics, Inc. shares at an average US$26.45 for US$249K, leaving 9,411 shares. Filed Oct 22, 2026 (Form 4).
- Bought
- 9,411 shares
- Price
- US$26.45 average (US$26.38 to US$26.92)
- Value
- US$249K
- Holding after
- 9,411 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Common Stock | Buy | 8,239 | US$26.38 | 8,239 | Indirect |
| Oct 22, 2026 | Common Stock | Buy | 1,172 | US$26.92 | 9,411 | Indirect |
Source
Download original · View original at SEC